Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model

Archives of Virology

Volumn 155, Issue 9, 2010, Pages 1391-1399

  Voeten, J Theo M ^a   Kiseleva, Irina V ^a,b   Glansbeek, Harrie L ^a   Basten, Stephanie M C ^a   Drieszen van der Cruijsen, Sandra K M ^a   Rudenko, Larisa G ^b   van den Bosch, Han ^a   Heldens, Jacco G M ^a  

^a Nobilon Schering Plough   (Netherlands)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE;

ANIMAL; ARTICLE; BRAIN; CELL LINE; CHICK EMBRYO; DISEASE MODEL; DOG; FEMALE; GENETIC REASSORTMENT; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS B; MOUSE; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIROLOGY; VIRULENCE; INFLUENZA, HUMAN;

ANIMALS; BRAIN; CELL LINE; CHICK EMBRYO; DISEASE MODELS, ANIMAL; DOGS; FEMALE; HUMANS; INFLUENZA A VIRUS, H2N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; REASSORTANT VIRUSES; VACCINES, ATTENUATED; VIRULENCE;

CERCOPITHECINE HERPESVIRUS 1; INFLUENZAVIRUS A; MUS; ORTHOMYXOVIRIDAE;

EID: 77957017797     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-010-0719-8     Document Type: Article

References (23)

1. Alexandrova GI (1996) Live influenza vaccine in Russia. In: Brown LE, Hampson AW, Webster RG (eds) Proceedings of the third international conference on options for the control of influenza, Cairns, Australia. Elsevier, Amsterdam pp 123-128.
2. Anonymous (2003) Points to consider on the development of live attenuated influenza vaccines. EMEA/CPMP/BWP/2289/01.
3. Glasgow JF (2006) Reye's syndrome: the case for a causal link with aspirin. Drug Saf 29: 1111-1121.
4. Govorkova EA, Rehg JE, Krauss S, Yen H-L, Guan Y, Peiris M, Nguyen TD, Hanh TH, Puthavathana P et al (2005) Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol 79: 2191-2198.
5. Govorkova EA, Webby RJ, Humberd J, Seiler JP, Webster RG (2006) Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis 194: 159-167.
6. Hayase Y, Tobita K (1997) Influenza virus and neurological disease. Psychiatry Clin Neurosci 51: 181-184.
7. Ito Y, Ichiyama T, Kimura H, Shibata M, Ishiwada N, Kuroki H, Furukawa S, Morishima T (1999) Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol 58: 420-425.
8. Kiseleva IV, Voeten JTM, Teley LCP, Larionova NV, Drieszen-van der Cruijsen SKM, Basten SMC, Heldens JGM, van den Bosch H, Rudenko LG (2010) PB2 and PA genes control the expression of the temperature sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus. J Gen Virol 91: 931-937.
9. Klimov AI, Egorov AY, Medvedeva TE, Gamble WC, Rudenko LG, Alexandrova GI, Cox NJ (1995) Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol 76: 1521-1525.
10. Klimov AI, Kiseleva IV, Alexandrova GI, Cox NJ (2001) Genes coding for polymerase proteins are essential for attenuation of the cold-adapted A/Leningrad/134/17/57 (H2N2) influenza virus. Int Congr Ser 1219: 955-959.
11. Kuiken T, Taubenberger J (2008) Pathology of human influenza revisited. Vaccine 26(Suppl 4): D59-D66.
12. Maines TR, Lu XH, Erb SM, Edwards L, Cuarner J, Greer PW, Nguyen DC, Szretter KJ, Chen L-M et al (2005) Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol 79: 11788-11800.
13. Maurizi CP (1985) Why was the 1918 pandemic so lethal? The possible role of a neurovirulent neuraminidase. Med Hypotheses 16: 1-5.
14. Morishima T, Togashi T, Yokota S, Okuno Y, Miyazaki C, Tashiro M, Okabe N, The Collaborative Study Group on Influenza-Associated Encephalopathy in Japan (2002) Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 35: 512-517.
15. Munster VJ, de Wit E, van den Brand JMA, Herfst S, Schrauwen EJA, Bestebroer TM, van de Vijver D, Boucher CA, Koopmans M et al (2009) Pathogensis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325: 481-483.
16. Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27: 493-497.
17. Starko KM, Ray CG, Dominguez LB, Stromberg WL, Woodall DF (1980) Reye's syndrome and salicylate use. Pediatrics 66: 859-864.
18. Stuart-Harris CH (1939) A neurotropic strain of human influenza virus. Lancet 1: 497-499.
19. Togahsi T, Matsuzono Y, Narita M, Morishima T (2004) Influenza-associated acute encephalopathy in Japanese children in 1994-2002. Virus Res 103: 75-78.
20. Toovey S (2008) Influenza-associated central nervous system dysfunction: a literature review. Travel Med Infect Dis 6: 114-124.
21. van der Laan JW, Herberts C, Lambkin-Williams R, Boyers A, Mann AJ, Oxford J (2008) Animal Models in influenza vaccine testing. Expert Rev Vaccines 7: 783-793.
22. Ward AC (1996) Neurovirulence of influenza A virus. J Neurovirol 2: 139-151.
23. Zitzow LA, Rowe T, Morken T, Shieh W-J, Zaki S, Katz JM (2002) Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J Virol 76: 4420-4429.